Biomedical Advanced Research and Development Authority

Project NextGen: Enablers for Innovative COVID-19 Vaccine Manufacturing

Virtual Workshop | July 20, 2023, at 1:00 p.m. ET.

BARDA will host a virtual workshop to gather feedback from the vaccine development and manufacturing communities and identify opportunities that address vaccine manufacturing hurdles to meet the goals of Project NextGen.

The Biomedical Advanced Research and Development Authority (BARDA) provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks; pandemic influenza (PI), and emerging infectious diseases (EID).

Together with its industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats.

Partnering with BARDA

BARDA Strategic Plan

Doing Business with BARDA

TechWatch

Program Areas

CBRN
Chemical, Biological, Radiological, and Nuclear

AMR
Antimicrobial Resistance

PI
Pandemic Influenza

EID
Emerging Infectious Diseases

Portfolios

FDA Approvals

COVID-19 Portfolio

CBRN Portfolio

Innovation and Partnerships

Meet the Director

Dr. Gary Disbrow is the Director of the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services. Read More